Dominic Nicholas Jackson
Directeur/Bestuurslid bij Redx Oncology Ltd.
Profiel
Dominic Nicholas Jackson is currently a Director at Redx Oncology Ltd.
and a Member at The Chartered Institute For Securities & Investment.
Previously, he worked as the Chief Financial Officer & Executive Director at Redx Pharma Plc from 2017 to 2019.
He also worked as a Member at the Institute for Turnaround.
Actieve functies van Dominic Nicholas Jackson
Bedrijven | Functie | Begin |
---|---|---|
The Chartered Institute For Securities & Investment
The Chartered Institute For Securities & Investment General GovernmentGovernment The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Redx Oncology Ltd.
Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Dominic Nicholas Jackson
Bedrijven | Functie | Einde |
---|---|---|
REDX PHARMA PLC | Financieel Directeur/CFO | 31-01-2019 |
Institute for Turnaround
Institute for Turnaround Miscellaneous Commercial ServicesCommercial Services Institute for Turnaround operates as a non-profit organization. It engages in professional body for all those specialized and qualified individuals working in corporate sector. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
REDX PHARMA PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
The Chartered Institute For Securities & Investment
The Chartered Institute For Securities & Investment General GovernmentGovernment The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom. | Government |
Institute for Turnaround
Institute for Turnaround Miscellaneous Commercial ServicesCommercial Services Institute for Turnaround operates as a non-profit organization. It engages in professional body for all those specialized and qualified individuals working in corporate sector. The company is headquartered in London, the United Kingdom. | Commercial Services |
Redx Oncology Ltd.
Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Health Technology |